: The lawsuit seeks to recover damages for Caesar Stone investors under the federal securities laws, according to Market Watch. According to the lawsuit, Defendants made false and/or misleading statements and/or failed to disclose that: the cost of quartz increased significantly by approximately 20% in 2014 while Caesar Stone claimed in SEC filings the impact of the price rising was just 4%; independent lab tests revealed that Caesar Stone samples contained less quartz than advertised; Caesar Stone reported consolidated margins, gross margins, and EBITDA were overstated; the extent of and risk posed by a rising number of lawsuits for approximately 60 silicosis-related injuries or deaths suffered by workers and fabricators of its product in Israel was understated; the impact recent OSHA warnings concerning silicosis would have on the opening of a new U.S. facility and associated costs; and recent inspection reports revealed audit deficiencies related to revenue and inventory controls. CSTE, +1.03% ADRs from March 25, 2013 through August 18, 2015 of the important October 26, 2015 lead plaintiff deadline in the class action. On August 19, 2015, analyst firm Spruce Point Capital Management published a report on Caesar Stone describing the aforementioned false and misleading statements and failures of disclosure. If you wish to serve as lead plaintiff, you must move the Court no later than October 26, 2015. On this adverse news, Caesar Stone ADRs fell $3.68, or 7.6%, to close at $44.61 on August 19, 2015.
(news.financializer.com). As
reported in the news.
Tagged under , topics.